A live, attenuated recombinant West Nile virus vaccine. 2006

Thomas P Monath, and Jian Liu, and Niranjan Kanesa-Thasan, and Gwendolyn A Myers, and Richard Nichols, and Alison Deary, and Karen McCarthy, and Casey Johnson, and Thomas Ermak, and Sunheang Shin, and Juan Arroyo, and Farshad Guirakhoo, and Jeffrey S Kennedy, and Francis A Ennis, and Sharone Green, and Philip Bedford
Acambis, 38 Sidney Street, Cambridge, MA 02139, USA. tom.monath@acambis.com

West Nile (WN) virus is an important cause of febrile exanthem and encephalitis. Since it invaded the U.S. in 1999, >19,000 human cases have been reported. The threat of continued epidemics has spurred efforts to develop vaccines. ChimeriVax-WN02 is a live, attenuated recombinant vaccine constructed from an infectious clone of yellow fever (YF) 17D virus in which the premembrane and envelope genes of 17D have been replaced by the corresponding genes of WN virus. Preclinical tests in monkeys defined sites of vaccine virus replication in vivo. ChimeriVax-WN02 and YF 17D had similar biodistribution but different multiplication kinetics. Prominent sites of replication were skin and lymphoid tissues, generally sparing vital organs. Viruses were cleared from blood by day 7 and from tissues around day 14. In a clinical study, healthy adults were inoculated with 5.0 log(10) plaque-forming units (PFU) (n = 30) or 3.0 log10 PFU (n = 15) of ChimeriVax-WN02, commercial YF vaccine (YF-VAX, n = 5), or placebo (n = 30). The incidence of adverse events in subjects receiving the vaccine was similar to that in the placebo group. Transient viremia was detected in 42 of 45 (93%) of ChimeriVax-WN02 subjects, and four of five (80%) of YF-VAX subjects. All subjects developed neutralizing antibodies to WN or YF, respectively, and the majority developed specific T cell responses. ChimeriVax-WN02 rapidly elicits strong immune responses after a single dose, and is a promising candidate warranting further evaluation for prevention of WN disease.

UI MeSH Term Description Entries
D008252 Macaca fascicularis A species of the genus MACACA which typically lives near the coast in tidal creeks and mangrove swamps primarily on the islands of the Malay peninsula. Burmese Long-Tailed Macaque,Crab-Eating Monkey,Cynomolgus Monkey,M. f. aurea,M. fascicularis,Macaca fascicularis aurea,Monkey, Crab-Eating,Monkey, Cynomolgus,Crab-Eating Macaque,Burmese Long Tailed Macaque,Crab Eating Macaque,Crab Eating Monkey,Crab-Eating Macaques,Crab-Eating Monkeys,Cynomolgus Monkeys,Long-Tailed Macaque, Burmese,Macaque, Burmese Long-Tailed,Macaque, Crab-Eating,Monkey, Crab Eating
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Thomas P Monath, and Jian Liu, and Niranjan Kanesa-Thasan, and Gwendolyn A Myers, and Richard Nichols, and Alison Deary, and Karen McCarthy, and Casey Johnson, and Thomas Ermak, and Sunheang Shin, and Juan Arroyo, and Farshad Guirakhoo, and Jeffrey S Kennedy, and Francis A Ennis, and Sharone Green, and Philip Bedford
January 2000, Viral immunology,
Thomas P Monath, and Jian Liu, and Niranjan Kanesa-Thasan, and Gwendolyn A Myers, and Richard Nichols, and Alison Deary, and Karen McCarthy, and Casey Johnson, and Thomas Ermak, and Sunheang Shin, and Juan Arroyo, and Farshad Guirakhoo, and Jeffrey S Kennedy, and Francis A Ennis, and Sharone Green, and Philip Bedford
August 2010, Vaccine,
Thomas P Monath, and Jian Liu, and Niranjan Kanesa-Thasan, and Gwendolyn A Myers, and Richard Nichols, and Alison Deary, and Karen McCarthy, and Casey Johnson, and Thomas Ermak, and Sunheang Shin, and Juan Arroyo, and Farshad Guirakhoo, and Jeffrey S Kennedy, and Francis A Ennis, and Sharone Green, and Philip Bedford
November 2007, Equine veterinary journal,
Thomas P Monath, and Jian Liu, and Niranjan Kanesa-Thasan, and Gwendolyn A Myers, and Richard Nichols, and Alison Deary, and Karen McCarthy, and Casey Johnson, and Thomas Ermak, and Sunheang Shin, and Juan Arroyo, and Farshad Guirakhoo, and Jeffrey S Kennedy, and Francis A Ennis, and Sharone Green, and Philip Bedford
November 2004, Journal of virology,
Thomas P Monath, and Jian Liu, and Niranjan Kanesa-Thasan, and Gwendolyn A Myers, and Richard Nichols, and Alison Deary, and Karen McCarthy, and Casey Johnson, and Thomas Ermak, and Sunheang Shin, and Juan Arroyo, and Farshad Guirakhoo, and Jeffrey S Kennedy, and Francis A Ennis, and Sharone Green, and Philip Bedford
September 2003, Virology,
Thomas P Monath, and Jian Liu, and Niranjan Kanesa-Thasan, and Gwendolyn A Myers, and Richard Nichols, and Alison Deary, and Karen McCarthy, and Casey Johnson, and Thomas Ermak, and Sunheang Shin, and Juan Arroyo, and Farshad Guirakhoo, and Jeffrey S Kennedy, and Francis A Ennis, and Sharone Green, and Philip Bedford
June 2005, Vaccine,
Thomas P Monath, and Jian Liu, and Niranjan Kanesa-Thasan, and Gwendolyn A Myers, and Richard Nichols, and Alison Deary, and Karen McCarthy, and Casey Johnson, and Thomas Ermak, and Sunheang Shin, and Juan Arroyo, and Farshad Guirakhoo, and Jeffrey S Kennedy, and Francis A Ennis, and Sharone Green, and Philip Bedford
August 2001, Trends in molecular medicine,
Thomas P Monath, and Jian Liu, and Niranjan Kanesa-Thasan, and Gwendolyn A Myers, and Richard Nichols, and Alison Deary, and Karen McCarthy, and Casey Johnson, and Thomas Ermak, and Sunheang Shin, and Juan Arroyo, and Farshad Guirakhoo, and Jeffrey S Kennedy, and Francis A Ennis, and Sharone Green, and Philip Bedford
December 2011, Current neurology and neuroscience reports,
Thomas P Monath, and Jian Liu, and Niranjan Kanesa-Thasan, and Gwendolyn A Myers, and Richard Nichols, and Alison Deary, and Karen McCarthy, and Casey Johnson, and Thomas Ermak, and Sunheang Shin, and Juan Arroyo, and Farshad Guirakhoo, and Jeffrey S Kennedy, and Francis A Ennis, and Sharone Green, and Philip Bedford
May 2001, Current drug targets. Infectious disorders,
Thomas P Monath, and Jian Liu, and Niranjan Kanesa-Thasan, and Gwendolyn A Myers, and Richard Nichols, and Alison Deary, and Karen McCarthy, and Casey Johnson, and Thomas Ermak, and Sunheang Shin, and Juan Arroyo, and Farshad Guirakhoo, and Jeffrey S Kennedy, and Francis A Ennis, and Sharone Green, and Philip Bedford
April 2007, Virus research,
Copied contents to your clipboard!